Wang, W., Jiang, X., Song, Z., & Zhang, Y. (2016). Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor. Onco Targets Ther.
Chicago-tyylinen lähdeviittausWang, Wenxian, Xiaowen Jiang, Zhengbo Song, ja Yiping Zhang. "Patients Harboring EGFR Mutation After Primary Resistance to Crizotinib and Response to EGFR-tyrosine Kinase Inhibitor." Onco Targets Ther 2016.
MLA-viiteWang, Wenxian, Xiaowen Jiang, Zhengbo Song, ja Yiping Zhang. "Patients Harboring EGFR Mutation After Primary Resistance to Crizotinib and Response to EGFR-tyrosine Kinase Inhibitor." Onco Targets Ther 2016.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.